- Founded
- 2010
- Stage
- Series A
- Invested
- 2021
- Status
- Private
Seismic Therapeutic is The Machine Learning Immunology Company; a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to treat adaptive immune system dysregulation to treat autoimmune diseases. The company’s progress is driven by its expert team of drug developers that is integrating machine learning to open new, better and faster ways to make medicines for patients.